| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/01/2008 | US20080103136 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle |
| 05/01/2008 | US20080103123 4-phenyl-3-substituted pyridin compounds such as tert-Butyl 4-[({5-[4-(methylsulfonyl)phenyl]pyridin-2-yl}oxy)methyl]-piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 05/01/2008 | US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination |
| 04/30/2008 | EP1916247A1 Activator of peroxisome proliferator activated receptor |
| 04/30/2008 | EP1916240A1 Pyridazine derivatives |
| 04/30/2008 | EP1915370A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 04/30/2008 | EP1915368A1 Salts and polymorphs of a vergf-r inhibitor |
| 04/30/2008 | EP1915351A1 Quinazoline derivatives useful in cancer treatment |
| 04/30/2008 | EP1915350A1 Amide derivatives |
| 04/30/2008 | EP1915345A1 Fluoro substituted 2-oxo azepan derivatives |
| 04/30/2008 | EP1727814B1 Nucleoside analogues with antiviral activity |
| 04/30/2008 | CN101171249A Method for producing indole derivative having piperidine ring |
| 04/30/2008 | CN101171248A 3-mono- and 3,5-disubstituted piperidine derivatives as renin inhibitors |
| 04/30/2008 | CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors |
| 04/30/2008 | CN101171238A (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor |
| 04/30/2008 | CN101171015A Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 04/30/2008 | CN101171012A Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 04/30/2008 | CN100384843C CGRP receptor antagonists |
| 04/30/2008 | CN100384838C Novel benzylpiperidine compound |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/30/2008 | CN100384836C Novel cyclic amide derivatives |
| 04/30/2008 | CN100384833C Therapeutic chroman compounds |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384421C N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 04/29/2008 | US7365207 Process for the production of chiral propionic acid derivatives |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365088 Indazole-derivatives as factor Xa inhibitors |
| 04/29/2008 | US7365087 Oxazole derivatives of tetracyclines |
| 04/29/2008 | US7365084 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/29/2008 | US7365082 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 04/29/2008 | US7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365066 Pyrazolopyridine derivatives as pharmaceutical agents |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365063 5-HT6 receptor and/or 5-HT2A receptor modulators; CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, sleep disorders, feeding disorders |
| 04/29/2008 | US7364804 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2008049047A2 Quinoline compounds |
| 04/24/2008 | WO2008048914A1 Polycyclic compounds which modulate the cb2 receptor |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008046919A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | WO2008046226A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008011080A3 Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 04/24/2008 | WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097099 Insecticides; for human or veterinary medicine; preparing heterocyclic amide and imine derivatives |
| 04/24/2008 | US20080097096 Preparing a solution of mycophenolic acid in acetone, combining a base with sodium methoxide, sodium ethoxide, or sodium hydroxide to precipitate the crystalline form |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096925 Analgesics for neuropathy, surgery, nervous system disorders, headaches, arthritis, psoriasis, respiratory system disorders, and gastrointestinal disorders; ethyl 4-phenyl-4-[1-(phenylmethyl)-1H-imidazol-2-yl]-1-piperidinecarboxylate; |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/24/2008 | US20080096921 Farnesoid x receptor agonists |
| 04/24/2008 | US20080096898 Organic Compounds |
| 04/24/2008 | US20080096888 Novel compounds as opioid receptor modulators |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096886 amidation of 3-(benzyloxy)-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid via the 2-acid chloride and then reaction with an amine; hydrolysis or catalytic hydrogenation to deprotect 3-hydroxy group; high yields for industrial application; the 3-(benzyloxy)-2-carboxamide intermediate |
| 04/24/2008 | US20080096885 Methyl 1-(2-fluorophenyl)-2-[(3-methoxy-2-phenylquinolin-4-yl)carbonyl]hydrazinecarboxylate; schizophrenia |
| 04/24/2008 | US20080096884 phosphodiesterase inhibitors; inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 04/24/2008 | US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 04/24/2008 | US20080096882 PDE4 (Phosphodiesterase) inhibitors; respiratory diseases, gastrointestinal diseases, inflammation the joints, skin or eyes, cancers, or diseases of the peripheral or central nervous system |
| 04/24/2008 | US20080096881 Quinazoline Derivatives |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096879 More potent analogs of FR901464 from Pseudomonas sp. No. 2663 culture and chemical synthesis; anticancer agents; intermediates |
| 04/24/2008 | US20080096877 Glucokinase activators; prophylaxis or treatment of diabetes, obesity; sulfonamide or sulfonate-functional thiazole or thiadiazole-substituted indoles; N,N-dimethyl-2-{4-[(2-{7-[methyl(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetamide for example |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096874 Oxadiazole Derivative as Dgat Inhibitors |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | US20080096843 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example |
| 04/24/2008 | CA2666590A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 04/24/2008 | CA2666508A1 Quinoline compounds |
| 04/24/2008 | CA2664849A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/23/2008 | EP1912996A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912982A2 Novel heterocyclic nf- b inhibitors |
| 04/23/2008 | EP1912980A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 04/23/2008 | EP1912979A2 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 04/23/2008 | EP1912978A2 Ppar / agonists and processes of preparing |
| 04/23/2008 | EP1912977A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1912976A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912957A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1912948A1 Antibacterial quinoline derivatives |
| 04/23/2008 | EP1912940A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1912649A2 Quinoline derivatives as antibacterial agents |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1054875B1 Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166736A Polymorph form II of tanaproget |
| 04/23/2008 | CN101166735A Novel oxadiazole derivatives and their medical use |
| 04/23/2008 | CN101166728A Method for producing alkyl anilides |
| 04/23/2008 | CN101166726A Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 04/23/2008 | CN101166725A Pyridylacetic acid compound |